Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Depreciation" stands at 7.39 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Johnson & Johnson's third quarter result of 1.78 Billion USD for the item "Depreciation" represents a decrease of -8.54 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 1.78 Billion USD for the item "Depreciation" represents a decrease of -3.74 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 7.39 Billion USD for the item "Depreciation" represents a decrease of -0.93 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.40 percent compared to the value the year prior.
The 1 year change in percent is 1.40.
The 3 year change in percent is 4.93.
The 5 year change in percent is 3.95.
The 10 year change in percent is 99.46.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Depreciation | 905,699,262,464.00 |
![]() | AbbVie Inc - Depreciation | 399,570,305,024.00 |
![]() | Roche Holding AG - Depreciation | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Depreciation | 280,205,508,085.11 |
![]() | Novartis AG - Depreciation | 255,096,620,580.91 |